David Dornan

Insider Reports History

Location
Redwood City, CA
Signature
s/ Stephen Rodin, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Dornan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Elevation Oncology, Inc. CHIEF SCIENTIFIC OFFICER Restricted Stock Unit 37,500 $19,125 $0.5100 15 Feb 2024 Direct
Elevation Oncology, Inc. CHIEF SCIENTIFIC OFFICER Restricted Stock Unit 28,125 $18,892 $0.6717 15 Feb 2025 Direct
Elevation Oncology, Inc. CHIEF SCIENTIFIC OFFICER Common Stock 5,223 $3,508 $0.6717 15 Feb 2025 Direct
Aadi Bioscience, Inc. Chief Scientific Officer Stock Option (right to buy) 687,979 04 Mar 2025 Direct
Elevation Oncology, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (Right to Buy) 225,000 15 Feb 2024 Direct
Bolt Biotherapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 210,000 18 Feb 2022 Direct

Insider Reports Filed by David Dornan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
WHWK Aadi Bioscience, Inc. 04 Mar 2025 1 $0 4 Chief Scientific Officer 04 Mar 2025, 18:11
WHWK Aadi Bioscience, Inc. 18 Feb 2025 0 $0 3 Chief Scientific Officer 18 Feb 2025, 16:58
ELEV Elevation Oncology, Inc. 15 Feb 2025 3 -$2,789 4 CHIEF SCIENTIFIC OFFICER 19 Feb 2025, 16:15
ELEV Elevation Oncology, Inc. 15 Feb 2024 2 $0 4 CHIEF SCIENTIFIC OFFICER 20 Feb 2024, 16:52
ELEV Elevation Oncology, Inc. 15 Feb 2023 1 $0 4 CHIEF SCIENTIFIC OFFICER 17 Feb 2023, 15:26
ELEV Elevation Oncology, Inc. 06 Jan 2023 1 $0 4 CHIEF SCIENTIFIC OFFICER 10 Jan 2023, 15:27
ELEV Elevation Oncology, Inc. 14 Mar 2022 1 $0 4 Chief Scientific Officer 16 Mar 2022, 17:46
ELEV Elevation Oncology, Inc. 14 Mar 2022 0 $0 3 Chief Scientific Officer 16 Mar 2022, 17:42
BOLT Bolt Biotherapeutics, Inc. 18 Feb 2022 1 $0 4 Chief Scientific Officer 23 Feb 2022, 20:19